Wound Healing Effects of HO/03/03 In Patients With Diabetic Neuropathic Plantar and Venous Ulcers, Pilot Study.

计划入组 22 人 · 首次发布于 2006 年 6 月 20 日

Protocol CAUSE-03 / CHEETAH

计划入组 310 人 · 首次发布于 2023 年 11 月 18 日

Safety and Efficacy of HO/03/03 10μg in the Treatment of Plantar Neuropathic Diabetic Foot Ulcers

计划入组 196 人 · 首次发布于 2009 年 6 月 23 日

CLBS-03

Ab-03

AP-03

山西迈特大药厂

CENTRE HOSPITALIER GUILLAUME REGNIER

France

Talphera

United States

Phase 2 Trial Shows Promise: Tislelizumab Plus Chemotherapy Demonstrates Strong Results in Advanced Gastroesophageal Cancer

Chinese Researchers Discover Novel HLA Allele HLA-DQB1*03:03:38 with Clinical Promise

NS Pharma's NS-050/NCNP-03 Receives FDA Rare Pediatric Disease Designation for Duchenne Muscular Dystrophy